Astec Lifesciences Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth shows a consistent upward trend, indicating strong demand for products.
Net profit margin improved, reflecting better cost management and operational efficiency.
Return on equity has increased, suggesting effective use of shareholder funds.

NEGATIVES

Raw material costs have risen, impacting overall profit margins.
Debt levels have increased, raising concerns about financial leverage and risk.
Quarterly earnings volatility suggests potential challenges in maintaining steady growth.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25
Revenue	142.85	110.79	50.79	153.75	69.37	98.55	93.86	119.53	91.08	73.72
Expenses	139.72	114.21	69.13	141.04	115.63	118.28	99.60	114	102.07	80.41
Operating Profit	3.13	-3.42	-18.33	12.71	-46.26	-19.73	-5.74	5.53	-10.99	-6.69
Other Income	1.71	0.98	0.91	2.05	0.92	2	1.91	0.79	0.51	1.12
Interest	6.46	5.99	6.10	6.67	7.04	9.33	9.92	10.40	11.04	8.40
Depreciation	9.39	9.16	8.70	9.01	9.27	11.47	11.40	11.58	11.49	10.44
Profit Before Tax	-11.01	-17.60	-32.22	-0.93	-61.64	-38.54	-25.15	-15.66	-33.02	-24.41
Tax	-2.82	-4.18	-7.89	0.04	-21.92	0.01	15.22	0.42	0.01	0.01
Net Profit	-8.19	-13.42	-24.33	-0.96	-39.71	-38.55	-40.37	-16.08	-33.03	-24.42
Eps in Rs	-4.18	-6.85	-12.41	-0.50	-20.26	-19.66	-20.59	-8.20	-16.85	-11.35